About Capital Rx
Capital Rx is a private company based in New York, New York. It has reported $499,644,728 raised in six offerings on Form D since July 2019. Its chief executive is A. Loiacono.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2025 | Sep 26, 2025 | $230,820,898of $232.8M target | 8 | $28.8M | EquityRule 506(b) | Form D ↗ |
| Mar 6, 2024 | Mar 22, 2024amended Mar 22, 2024 | $114,999,999of $312.4M target | 1 | $114.9M | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| May 27, 2022 | Jun 13, 2022 | $105,999,993fully sold | 9 | $11.7M | EquityRule 506(b) | Form D ↗ |
| Apr 1, 2021 | Jul 14, 2021 | $3,480,430fully sold | 4 | $870K | OptionsRule 506(b) | Form D ↗ |
| Dec 21, 2020 | Jan 5, 2021 | $31,960,628of $52.9M target | 4 | $7.9M | EquityRule 506(b) | Form D ↗ |
| Jul 2, 2019 | Jul 19, 2019 | $12,382,780of $16.3M target | 1 | $12.3M | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, six offerings | $499,644,728 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Capital Rx's Form D filed Sep 26, 2025.
JK
Jared Kesselheim
Director
MK
Mark Kandrysawtz
Director
LM
Lenard Marcus
Director
RK
Ryan Kelly
Director
RM
Robert Mittendorff
Director
KH
Kevin Hill
Director
HM
Holly Maloney
Director
MK
Mostafa Kamal
Director
AL
A. Loiacono
Chief Executive Officer and director
DD
Daniel Delmastro
Director
Earlier filings also listed Feby Abraham (director, last listed Mar 2024), Laleh Alemzadeh (secretary, last listed Jun 2022), Joseph Alexander (executive officer, last listed Jun 2022), Laura Alemzadeh (secretary, last listed Jan 2021) and A.j. Loiacono (ceo and director, last listed Jul 2019).